267 related articles for article (PubMed ID: 15737873)
1. Autologous and allogeneic stem cell transplantation in follicular lymphoma.
Van Besien K
Transfus Apher Sci; 2005 Feb; 32(1):45-53. PubMed ID: 15737873
[TBL] [Abstract][Full Text] [Related]
2. Stem cell transplantation in follicular lymphoma: progress at last?
Tse WW; Lazarus HM; Van Besien K
Bone Marrow Transplant; 2004 Dec; 34(11):929-38. PubMed ID: 15489883
[TBL] [Abstract][Full Text] [Related]
3. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.
Van Besien K
Blood Rev; 2006 Sep; 20(5):235-44. PubMed ID: 16513231
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
Pettengell R
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
6. Favorable overall survival with fully myeloablative allogeneic stem cell transplantation for follicular lymphoma.
Kuruvilla J; Pond G; Tsang R; Gupta V; Lipton JH; Messner HA
Biol Blood Marrow Transplant; 2008 Jul; 14(7):775-82. PubMed ID: 18541196
[TBL] [Abstract][Full Text] [Related]
7. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?
Willemze R; Labar B
Semin Hematol; 2007 Oct; 44(4):267-73. PubMed ID: 17961726
[TBL] [Abstract][Full Text] [Related]
8. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
Laport GG
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
[TBL] [Abstract][Full Text] [Related]
9. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
Nademanee A; Forman SJ
Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
[TBL] [Abstract][Full Text] [Related]
10. In vivo purging and relapse prevention following ASCT.
Gisselbrecht C
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of stem cell transplants in lymphomas.
Jantunen E; Sureda A
Biol Blood Marrow Transplant; 2012 May; 18(5):660-73. PubMed ID: 21963876
[TBL] [Abstract][Full Text] [Related]
13. Conventional allograft and autograft in low grade lymphoma.
Avivi I; Goldstone AH
Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188
[TBL] [Abstract][Full Text] [Related]
14. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
[TBL] [Abstract][Full Text] [Related]
16. Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.
Thomson KJ; Peggs KS; Smith P; Cavet J; Hunter A; Parker A; Pettengell R; Milligan D; Morris EC; Goldstone AH; Linch DC; Mackinnon S
Bone Marrow Transplant; 2008 May; 41(9):765-70. PubMed ID: 18195684
[TBL] [Abstract][Full Text] [Related]
17. Current management of follicular lymphomas.
Hiddemann W; Buske C; Dreyling M; Weigert O; Lenz G; Unterhalt M
Br J Haematol; 2007 Jan; 136(2):191-202. PubMed ID: 17073892
[TBL] [Abstract][Full Text] [Related]
18. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
[TBL] [Abstract][Full Text] [Related]
20. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?
Fernandez HF; Escalón MP; Pereira D; Lazarus HM
Bone Marrow Transplant; 2007 Sep; 40(6):505-13. PubMed ID: 17589535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]